Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study of INCMGA00012 (PD-1 Inhibitor), INCB001158 (Arginase Inhibitor), and the Combination in Japanese Participants With Advanced Solid Tumors

NCT03910530 is registered in ClinicalTrials.gov with Incyte Biosciences Japan GK as lead sponsor.

NCT NCT03910530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03910530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study of INCMGA00012 (PD-1 Inhibitor), INCB001158 (Arginase Inhibitor), and the Combination in Japanese Participants With Advanced Solid Tumors
Lead sponsor
Incyte Biosciences Japan GK
Phase
Phase 1
Overall status
Completed
Start date
July 22, 2019
Completion date
December 14, 2021
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors, metastatic solid tumors